Retatrutide is a synthetic peptide that acts as a triple agonist at GLP-1, GIP, and glucagon receptors. It has been studied in early-phase clinical research exploring its role in metabolic regulation and energy homeostasis. It is supplied here strictly for in vitro and laboratory research purposes.
Published clinical research has examined retatrutide as a potential investigational compound in metabolic studies. Findings are early-stage and have not resulted in approved therapeutic status in Canada.
Storage: Store lyophilized material at 2–8°C in a sealed vial, away from light and moisture. Once reconstituted, aliquot and store at -20°C to maintain integrity.
Disclaimer: This product is intended for research and laboratory use only. It is not approved for human consumption, veterinary use, or any therapeutic application. Not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified professional before handling. Must be 19+.
Explore more Metabolic research peptides →
📋 Storage, Quality & Research Information
Purity & Quality Testing
All TrueCanPeptides compounds are verified at ≥98% purity via HPLC and mass spectrometry by an independent third-party laboratory. A batch-specific Certificate of Analysis (COA) is available for every order.
Storage Guidelines
Lyophilized peptides should be stored at −20°C in a dry, desiccated environment away from light. Reconstituted solutions should be refrigerated at 2–8°C and used within 28 days. Requirements may vary — always refer to your product COA for specific handling guidance.
Reconstitution
For reconstitution guidance including solvent selection, step-by-step protocol, and concentration calculations, see our Peptide Reconstitution Guide.
Research Use Only. This product is sold for laboratory research purposes only. Not intended for human use, therapeutic application, self-administration, or diagnostic purposes. Not approved by Health Canada for human use. For research and educational purposes only.
Related products: Retatrutide 10mg
